Digital marketing is the next frontier for pharma companies but,
despite widespread interest in the medium, few UK companies have grasped the nettle and tried to engage with patients and prescribers using new online tools. A lack of clarity on what is allowed is one factor perceived to be holding companies back.
This InPharm.com webcast will discuss how digital marketing initiatives can be carried out under the UK’s self-regulatory Code of Practice, and provide real-world examples.
The speakers are: Alex Butler (Janssen), Peter Mas-Mollinedo (ICR-UK & IMI - Irish Medical Information), Steve Gray (Compliance Hub) and Dominic Tyer (Moderator - InPharm.com)